Definitive Contract 75N93018C00008
Award Date
7/1/18
Potential Completion Date
6/30/25
Potential Value
$17M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
University Of Washington
Ultimate Awardee
University Of Washington
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AN81 - R&D- Medical: Aids Research (Basic Research)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Seattle, WA 98195, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The University of Washington (UW) was awarded a $23,435,111.67 federal contract by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to establish and operate the Simian Vaccine Evaluation Unit (SVEU). This definitive cost-type contract, which does not have a set-aside designation, was awarded on June 22, 2006 and is scheduled for completion on June 21, 2014. UW, as a state-controlled institution of higher...
This delivery order award of $50,000 to the University of Washington (UW) was made under the National Institute of Allergy and Infectious Diseases (NIAID) Animal Models of Infectious Diseases 2010-2017 indefinite delivery contract. The award is for animal models of infectious diseases research and does not have a set-aside designation. UW is a leading research university that has received numerous federal contract and grant awards across various disciplines, often acting as both a prime...
The University of Washington (UW) was awarded a $9,170,967.00 definitive contract from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), for "POPULATION GENETICS ANALYSIS PROGRAMS: IMMUNITY TO VACCINES". The contract, which does not have a set-aside designation, was awarded on September 30, 2004 and has an ultimate completion date of November 19, 2013. UW is a leading public research university that leverages...
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Washington (UW). The contract, valued at $7,822,728.37, is for biomedical research services under the Population Genetics Analysis Program. The contract is a definitive, cost-no-fee type and does not have a set-aside designation. UW is a leading public research university that has extensive experience in supporting federal agencies through prime contract and grant...
The University of Washington, a public research university in Seattle, Washington, was awarded a $7,923,187.00 definitive contract from the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract, which does not have a set-aside designation, is for biomedical (basic) services with a completion date of April 30, 2008. The University of Washington has a long history of providing specialized laboratory testing,...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Washington (UW) to provide QRT-PCR testing analysis services. The contract has a ceiling value of $194,400.00 and a period of performance ending August 18, 2025. The contract does not have a set-aside designation. UW is a leading research university that has received numerous prime federal contract and grant awards to support a...
This is a $5,491,304.00 cost-reimbursement contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Washington (UW) to conduct large-scale T-cell epitope discovery research. The contract has a completion date of September 29, 2025 and is not a set-aside award. As the prime contractor, UW will perform the research work. UW has a subcontract with Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), a foreign government hospital, to...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Washington School of Medicine. The $23,012,457.00 firm-fixed-price contract is for specialized biomedical services and laboratory testing to support federal healthcare and research initiatives. The School of Medicine, which is a part of the University of Washington, has extensive expertise in clinical pathology,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $5,571,430.00 definitive cost contract to the University of Washington to develop protective T cell epitopes and immune receptors for sexually transmitted infections. The contract has a completion date of September 29, 2025 and does not include a set-aside designation. The University of Washington is a leading research university that has received prior federal contract and grant awards from agencies such as the...
This federal contract award, valued at $32,396.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to the University of Washington School of Medicine, doing business as the University of Washington Department of Laboratory Medicine. The contract, which is a firm-fixed price purchase order, is for Immunoplex Sequencing services. The award was made on a sole-source basis, as NIAID determined that the University of...